Hjem › Geografisk atrofi › Mississippi
Geografisk atrofi kliniske forsøg i Mississippi
3 studier for Geografisk atrofi søger deltagere på steder i Mississippi.
Officiel studietekst (engelsk)
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Specialists of Mississippi - Hattiesburg, Hattiesburg
RekruttererFase 1/2
Alder 55 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Mississippi Retina Associates, Madison
- Deep Blue Retina Clinical Research PLLC, Southaven
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Deep Blue Retina, Southaven
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT03178149Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.